If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Acquisition

2 Oct 2018 07:00

RNS Number : 5953C
Scapa Group PLC
02 October 2018
 

 

2 October 2018

LEI No. 213800QIPVTK5ES5UU36

 

 

Scapa Group plc ("Scapa" or "the Group")

 

 

Completion of Acquisition of Systagenix Advanced Wound Dressing Facility in Gargrave

Entering a 5-year exclusive manufacturing and supply agreement

 

Further to the announcement made on 13 September 2018, Scapa Group plc (AIM: SCPA) is pleased to announce that its acquisition of the share capital of Systagenix Wound Management Manufacturing Limited completed on 1 October 2018. In addition, Scapa and Acelity have now entered into the exclusive five-year manufacturing and supply agreement for Systagenix advanced wound care products that are currently manufactured in the Gargrave facility, with immediate effect.

 

 

 

For further information:

 

Scapa Group plc

Heejae Chae - Group Chief Executive

Oskar Zahn - Chief Financial Officer

 

 

 0161 301 7430

Numis Securities Limited

(Nominated Adviser and Joint Broker)

Richard Thomas/Mark Lander

 020 7260 1000

 

 

 

Berenberg

(Joint Broker)

Chris Bowman

 

Weber Shandwick Financial PR

Nick Oborne

 

 020 3207 7800

 

 

 

020 7067 0000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQBUBDGRSGBGIB
Date   Source Headline
15th Mar 20122:18 pmRNSHolding(s) in Company
12th Mar 20125:11 pmRNSHolding(s) in Company
9th Mar 201210:33 amRNSTotal Voting Rights
7th Mar 20121:25 pmRNSHolding(s) in Company
24th Feb 20128:49 amRNSHolding(s) in Company
21st Feb 201211:10 amRNSDirector/PDMR Shareholding
21st Feb 201211:08 amRNSDirector/PDMR Shareholding
14th Feb 201211:53 amRNSHolding(s) in Company
3rd Feb 20122:44 pmRNSHolding(s) in Company
1st Feb 20123:51 pmRNSBlock Listing Application and Total Voting Rights
31st Jan 20122:25 pmRNSDirector/PDMR Shareholding
31st Jan 20122:23 pmRNSDirector/PDMR Shareholding
6th Jan 20123:47 pmRNSHolding(s) in Company
5th Jan 20122:26 pmRNSHolding(s) in Company
29th Dec 201112:16 pmRNSHolding(s) in Company
23rd Dec 201111:02 amRNSHolding(s) in Company
23rd Dec 201110:45 amRNSHolding(s) in Company
22nd Dec 20117:00 amRNSAcquisition
29th Nov 20117:00 amRNSHalf Yearly Report
25th Nov 20113:52 pmRNSHolding(s) in Company
17th Nov 20119:46 amRNSHolding(s) in Company
11th Oct 20117:00 amRNSSite Visit
11th Oct 20117:00 amRNSTrading Statement
7th Oct 20113:14 pmRNSHolding(s) in Company
27th Sep 20115:05 pmRNSIssue of Equity
23rd Sep 20115:00 pmRNSHolding(s) in Company
22nd Sep 20115:44 pmRNSHolding(s) in Company
22nd Sep 20115:42 pmRNSHolding(s) in Company
1st Sep 201110:54 amRNSDirector/PDMR Shareholding
1st Sep 201110:53 amRNSDirector/PDMR Shareholding
23rd Aug 201111:08 amRNSHolding(s) in Company
4th Aug 20111:28 pmRNSHolding(s) in Company
1st Aug 20113:53 pmRNSHolding(s) in Company
27th Jul 20115:25 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSAGM Statement
20th Jul 20112:10 pmRNSAdditional Listing
22nd Jun 20119:01 amRNSNotice of AGM
9th Jun 20119:32 amRNSHolding(s) in Company
7th Jun 20115:34 pmRNSHolding(s) in Company
7th Jun 201111:33 amRNSHolding(s) in Company
3rd Jun 201110:47 amRNSAdditional Listing
26th May 201111:37 amRNSHolding(s) in Company
26th May 20117:00 amRNSFinal Results
4th May 20119:47 amRNSHolding(s) in Company
4th May 20119:45 amRNSHolding(s) in Company
4th May 20119:43 amRNSHolding(s) in Company
26th Apr 20113:18 pmRNSNotice of Results
20th Apr 20112:23 pmRNSHolding(s) in Company
13th Apr 20117:00 amRNSTrading Statement
7th Apr 20119:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.